ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0280

Mast Cells Contribute to the Development of Lung Fibrosis via Inducing Myofibroblast Differentiation by TGF-β Production

Shinjiro Kaieda1, Masaki Okamoto2, Masaki Tominaga1 and Tomoaki Hoshino1, 1Kurume University School of Medicine, Kurume, Japan, 2Kyushu Medical Center, Fukuoka, Japan

Meeting: ACR Convergence 2021

Keywords: Fibrosing syndromes, mast cell, Myofibroblast, Transforming Growth Factor (TGF)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 6, 2021

Title: RA – Diagnosis, Manifestations, & Outcomes Poster I: Cardiovascular Pulmonary Disease (0268–0295)

Session Type: Poster Session A

Session Time: 8:30AM-10:30AM

Background/Purpose: Idiopathic pulmonary fibrosis is an interstitial lung disease of unknown etiology. The most critical event in the evolution of fibrosis is the appearance of activated myofibroblasts. Mast cells (MC) are reportedly involved in various inflammatory and fibrotic conditions, although little is known about their roles in interstitial lung disease (ILD). Since the pathogenic role of MC in ILD remains unclear, we examined whether MCs play a critical role in the development of pulmonary fibrosis.

Methods: Lung tissue was examined using histology and immunohistochemistry. The samples for biopsy were obtained from the involved lung tissue of 13 patients with idiopathic pulmonary fibrosis (IPF) and 13 patients with connective tissue disease (CTD)-associated-ILD (RA 7 systemic sclerosis 6). As a control, we used noncancerous lung sections of 10 patients who had undergone surgery for lung cancer. We used immunohistochemistry to identify and quantify tryptase-, prolyl-4-hydroxylase β-, and alpha-smooth muscle actin (α-SMA)-positive cells as MCs, fibroblasts, and myofibroblasts, respectively. The co-culture of the human mast cell line (HMC-1) with pulmonary fibroblasts was performed in a Transwell system. Fibroblasts cultured with or without HMC-1 cells were cytospun and the expression of α-SMA, a marker of myofibroblast differentiation, was examined by immunohistochemistry after 7 days of culture. The ACTA2 mRNA synthesis in the fibroblasts was evaluated by RT-qPCR. The conditioned medium for the fibroblast culture was obtained from HMC-1 cells stimulated with recombinant human IL-33 and stem cell factor for 24 hours. Fibroblasts were treated with HMC-1-conditioned medium for 24 hours and the ACTA2 mRNA synthesis in the fibroblasts was evaluated by RT-qPCR. Neutralization antibodies for human TGF-β1, 2, and 3 were used during the fibroblast culture with HMC-1-conditioned or standard culture media.

Results: MCs were significantly more numerous in the lung samples with IPF and CTD-ILD than in the control (Fig. 1a and b). MCs were proximal to the Elastica van Gieson (EVG)-stained fibrous tissue and pulmonary fibroblasts and myofibroblasts (Fig 1c, d, and e). We examined whether MCs induced pulmonary fibroblasts to differentiate into myofibroblasts. In the co-culture experiment, the ACTA2 mRNA level significantly increased compared to that in the control fibroblast monoculture (Fig. 2a). Consistently with this result, the upregulation of α-SMA in the fibroblasts during the co-culture was confirmed by immunohistochemistry. Furthermore, the ACTA2 mRNA was significantly upregulated in fibroblasts conditioned with the HMC-1 medium compared to that in fibroblasts cultured in a standard medium (Fig. 3). In addition, the neutralization of TGF-β abolished the ACTA2 mRNA upregulation in fibroblasts conditioned in the HMC-1 medium, thereby suggesting that HMC-1-derived TGF-β contributes to myofibroblast differentiation (Fig. 3).

Conclusion: The findings suggest a novel role for MCs in the development of lung fibrosis via TGF-β production-induced myofibroblast differentiation.


Disclosures: S. Kaieda, None; M. Okamoto, None; M. Tominaga, None; T. Hoshino, None.

To cite this abstract in AMA style:

Kaieda S, Okamoto M, Tominaga M, Hoshino T. Mast Cells Contribute to the Development of Lung Fibrosis via Inducing Myofibroblast Differentiation by TGF-β Production [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/mast-cells-contribute-to-the-development-of-lung-fibrosis-via-inducing-myofibroblast-differentiation-by-tgf-%ce%b2-production/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/mast-cells-contribute-to-the-development-of-lung-fibrosis-via-inducing-myofibroblast-differentiation-by-tgf-%ce%b2-production/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology